ArticleJournal of surgical oncology2026
AI Risk Prediction Tools for Autologous Breast Reconstruction.
Article in Journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutologous breast reconstruction offers patients a durable and natural-appearing option after mastectomy. However, complication risks include flap loss, infection, and delayed wound healing. This study developed both traditional statistical and machine learning (ML) models to predict the risk of developing a 90-day postoperative complication after autologous reconstruction.
methodsPatient data were retrospectively collected for patients who underwent abdominal-based autologous breast reconstruction at Memorial Sloan Kettering Cancer Center (January 2015-September 2024). Multivariable logistic regression models and supervised ML models were developed to predict infection, hematoma, seroma, delayed wound healing, and flap compromise.
results2,128 patients (3,249 flap reconstructions) were included. Overall, 90-day complications occurred in 475 (22.3%) patients, including infection (10%), hematoma (6%), delayed healing (4.1%), seroma (3.9%), and flap compromise (2.8%). AUCs ranged from 0.60 to 0.66 (logistic regression) and 0.64 to 0.73 (ML). Higher BMI was associated with increased risk for seroma (OR: 1.1, 95% CI: 1.04-1.13) and neoadjuvant chemotherapy for infection (OR:1.72, 95% CI: 1.17-2.51). Key ML model predictors on SHAP analysis included age, BMI, and pre-reconstruction radiation.
conclusionIndividualized risk prediction models for complications after autologous breast reconstruction were developed using traditional statistics and ML. These models may help personalize treatment; however, further research is needed to enhance model predictive performance and clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.